tiprankstipranks
Innate Pharma SA (IPHYF)
OTHER OTC:IPHYF
Holding IPHYF?
Track your performance easily

Innate Pharma SA (IPHYF) Technical Analysis

27 Followers

Summary of all the Indicators

Overall Consensus
Neutral
9Bullish
3Neutral
10Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Innate Pharma SA’s (IPHYF) Moving Averages Convergence Divergence (MACD) indicator is 0.29, suggesting Innate Pharma SA is a Sell.
Innate Pharma SA’s (IPHYF) 20-Day exponential moving average is 1.98, while Innate Pharma SA’s (IPHYF) share price is $2.9, making it a Buy.
Innate Pharma SA’s (IPHYF) 50-Day exponential moving average is 1.84, while Innate Pharma SA’s (IPHYF) share price is $2.9, making it a Buy.

Innate Pharma SA (IPHYF) Pivot Points

Dec 23, 2024, 04:49 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.55
1.82
2.36
2.63
3.17
3.44
3.98
Fibonacci
1.82
2.13
2.32
2.63
2.94
3.13
3.44
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Innate Pharma SA (IPHYF) Moving Averages

Dec 23, 2024, 04:49 AM
Period
Simple
Exponential
MA5
2.73Sell
2.48Sell
MA10
2.19Sell
2.27Sell
MA20
1.74Buy
1.98Buy
MA50
1.72Buy
1.84Buy
MA100
1.99Buy
1.94Buy
MA200
2.20Sell
2.15Sell
Innate Pharma SA’s (IPHYF) 10-Day exponential moving average is 2.27, while Innate Pharma SA’s (IPHYF) share price is $2.9, making it a Sell.
Innate Pharma SA’s (IPHYF) 100-Day exponential moving average is 1.94, while Innate Pharma SA’s (IPHYF) share price is $2.9, making it a Buy.
Innate Pharma SA’s (IPHYF) stock price is $2.9 and Innate Pharma SA’s (IPHYF) 50-day simple moving average is 1.72, creating a Buy signal.
Innate Pharma SA’s (IPHYF) stock price is $2.9 and Innate Pharma SA’s (IPHYF) 100-day simple moving average is 1.99, creating a Buy signal.
Innate Pharma SA’s (IPHYF) stock price is $2.9 and Innate Pharma SA’s (IPHYF) 200-day simple moving average is 2.20, creating a Sell signal.

Innate Pharma SA (IPHYF) Technical Indicators

Dec 23, 2024, 04:49 AM
Name
Value
Implied Action
RSI (14)
53.95
Neutral
STOCH (9,6)
81.51
Sell
STOCHRSI (14)
82.30
Sell
MACD (12,26)
0.29
Sell
ADX (14)
49.40
Neutral
Williams %R
-53.09
Buy
CCI (14)
47.36
Neutral
ATR (14)
0.48
-
Ultimate Oscillator
85.97
Buy
ROC
59.38
Buy
Innate Pharma SA’s (IPHYF) Relative Strength Index (RSI) is 53.95, creating a Neutral signal.
Innate Pharma SA’s (IPHYF) Trend Strength Indicator (ADX) is 49.40, creating a Neutral signal.
Innate Pharma SA’s (IPHYF) Commodity Channel Index (CCI) is 47.36, creating a Neutral signal.
Innate Pharma SA’s (IPHYF) Price Rate of Change (ROC) is 59.38, creating a Buy signal.

FAQ

Is IPHYF a Buy, Hold, or Sell?
Based on IPHYF’s technical indicators, IPHYF is a Hold.
    What is IPHYF’s RSI (14)?
    IPHYF’s RSI (14) is 53.95, which suggests IPHYF is a Neutral.
      What is IPHYF’s MACD?
      IPHYF’s MACD is 0.29, which suggests IPHYF is a Sell.
        What is IPHYF’s 5-day moving average?
        IPHYF’s 5-day moving average is 2.73, which suggests IPHYF is a Sell.
          What is IPHYF’s 20-day moving average?
          IPHYF 20-day moving average is 1.74, which suggests IPHYF is a Buy.
            What is IPHYF’s 50-day moving average?
            IPHYF’s 50-day moving average is 1.72, which suggests IPHYF is a Buy.
              What is IPHYF’s 200-day moving average?
              IPHYF’s 200-day moving average is 2.20, which suggests IPHYF is a Sell.
                What is IPHYF’s Williams % R (14)?
                IPHYF’s Williams % R (14) is -53.09, which suggests IPHYF is a Buy.
                  What is IPHYF’s CCI (14)?
                  IPHYF’s CCI (14) is 47.36, which suggests IPHYF is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis